![18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink 18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-020-04918-4/MediaObjects/259_2020_4918_Fig1_HTML.png)
18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink
![18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink 18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-020-04918-4/MediaObjects/259_2020_4918_Fig6_HTML.png)
18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink
![Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3880543/MediaObjects/41379_2002_Article_BF3880543_Fig2_HTML.jpg)
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
![Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment](https://www.frontiersin.org/files/Articles/528772/fneur-11-00754-HTML/image_m/fneur-11-00754-g001.jpg)
Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment
![Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease | Scientific Reports Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-44173-8/MediaObjects/41598_2019_44173_Fig1_HTML.png)
Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease | Scientific Reports
![Rozdíly mezi jednotlivými lymfodrenážními přístroji z hlediska účinnosti procedury - BS Systems s.r.o. Rozdíly mezi jednotlivými lymfodrenážními přístroji z hlediska účinnosti procedury - BS Systems s.r.o.](https://www.bs-systems.cz/wp-content/uploads/2020/01/MG_1902-658x400.jpg)
Rozdíly mezi jednotlivými lymfodrenážními přístroji z hlediska účinnosti procedury - BS Systems s.r.o.
![Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours | SpringerLink Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-021-05351-x/MediaObjects/259_2021_5351_Fig6_HTML.png)
Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours | SpringerLink
![Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures - Falgàs - 2020 - Human Brain Mapping - Wiley Online Library Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures - Falgàs - 2020 - Human Brain Mapping - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e38bdeea-2882-49c6-8bda-2209970fa2d1/hbm24925-fig-0002-m.jpg)
Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures - Falgàs - 2020 - Human Brain Mapping - Wiley Online Library
![Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.3880543/MediaObjects/41379_2002_Article_BF3880543_Fig1_HTML.jpg)
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
![Evaluation of D-isomers of 4-borono-2-18F-fluoro-phenylalanine and O-11C-methyl-tyrosine as brain tumor imaging agents: a comparative PET study with their L-isomers in rat brain glioma | EJNMMI Research | Full Text Evaluation of D-isomers of 4-borono-2-18F-fluoro-phenylalanine and O-11C-methyl-tyrosine as brain tumor imaging agents: a comparative PET study with their L-isomers in rat brain glioma | EJNMMI Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13550-018-0404-6/MediaObjects/13550_2018_404_Fig1_HTML.png)
Evaluation of D-isomers of 4-borono-2-18F-fluoro-phenylalanine and O-11C-methyl-tyrosine as brain tumor imaging agents: a comparative PET study with their L-isomers in rat brain glioma | EJNMMI Research | Full Text
Exposure to Bisphenol A Correlates with Early-Onset Prostate Cancer and Promotes Centrosome Amplification and Anchorage-Independent Growth In Vitro | PLOS ONE
![High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling | Cell Death & Disease High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-018-0903-4/MediaObjects/41419_2018_903_Fig1_HTML.png)